Prevalence and impact in work productivity of gastroesophageal reflux disease (GERD) in primary care patients with upper gastrointestinal (GI) symptoms using GerdQ - GerdQ-Greece

Study identifier:NIS-GGR-DUM-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A cross-sectional study on the prevalence and impact in work productivity of GERD in primary care patients with upper GI symptoms using the novel questionnaire GERD-Q. The Greek GERD-Q Study

Medical condition

Gastroesophageal Reflux Disease

Phase

N/A

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

889

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jul 2009

Primary Completion Date: 01 Dec 2009

Study Completion Date: 01 Dec 2009

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Upper-GI symptoms in primary-care patients	-

Documents available

CSR-NIS-GGR-DUM-2009-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information Center

1-877-240-9479

[email protected]

Investigators

Principal Investigator

Theodoros Rokkas

Henry Dynan Hospital, Athens, Greece